These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36731609)

  • 1. Reduction of anaerobic glycolysis contributes to angiotensin II-induced podocyte injury with foot process effacement.
    Chen Z; Zhu Z; Liang W; Luo Z; Hu J; Feng J; Zhang Z; Luo Q; Yang H; Ding G
    Kidney Int; 2023 Apr; 103(4):735-748. PubMed ID: 36731609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
    Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
    Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compromised glycolysis contributes to foot process fusion of podocytes in diabetic kidney disease: Role of ornithine catabolism.
    Luo Q; Liang W; Zhang Z; Zhu Z; Chen Z; Hu J; Yang K; Chi Q; Ding G
    Metabolism; 2022 Sep; 134():155245. PubMed ID: 35780908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of pyruvate kinase M2-mediated metabolic reprogramming during podocyte differentiation.
    Yuan Q; Miao J; Yang Q; Fang L; Fang Y; Ding H; Zhou Y; Jiang L; Dai C; Zen K; Sun Q; Yang J
    Cell Death Dis; 2020 May; 11(5):355. PubMed ID: 32393782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte specific deletion of PKM2 ameliorates LPS-induced podocyte injury through beta-catenin.
    Alquraishi M; Chahed S; Alani D; Puckett DL; Dowker PD; Hubbard K; Zhao Y; Kim JY; Nodit L; Fatima H; Donohoe D; Voy B; Chowanadisai W; Bettaieb A
    Cell Commun Signal; 2022 May; 20(1):76. PubMed ID: 35637461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FHL2 mediates podocyte Rac1 activation and foot process effacement in hypertensive nephropathy.
    Li SY; Chu PH; Huang PH; Hsieh TH; Susztak K; Tarng DC
    Sci Rep; 2019 Apr; 9(1):6693. PubMed ID: 31040292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.
    Qi W; Keenan HA; Li Q; Ishikado A; Kannt A; Sadowski T; Yorek MA; Wu IH; Lockhart S; Coppey LJ; Pfenninger A; Liew CW; Qiang G; Burkart AM; Hastings S; Pober D; Cahill C; Niewczas MA; Israelsen WJ; Tinsley L; Stillman IE; Amenta PS; Feener EP; Vander Heiden MG; Stanton RC; King GL
    Nat Med; 2017 Jun; 23(6):753-762. PubMed ID: 28436957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.
    Sonneveld R; van der Vlag J; Baltissen MP; Verkaart SA; Wetzels JF; Berden JH; Hoenderop JG; Nijenhuis T
    Am J Pathol; 2014 Jun; 184(6):1715-26. PubMed ID: 24731445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirt6 deficiency aggravates angiotensin II-induced cholesterol accumulation and injury in podocytes.
    Yang Q; Hu J; Yang Y; Chen Z; Feng J; Zhu Z; Wang H; Yang D; Liang W; Ding G
    Theranostics; 2020; 10(16):7465-7479. PubMed ID: 32642006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
    Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
    Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regeneration of glomerular metabolism and function by podocyte pyruvate kinase M2 in diabetic nephropathy.
    Fu J; Shinjo T; Li Q; St-Louis R; Park K; Yu MG; Yokomizo H; Simao F; Huang Q; Wu IH; King GL
    JCI Insight; 2022 Mar; 7(5):. PubMed ID: 35133981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin system within the diabetic podocyte.
    Márquez E; Riera M; Pascual J; Soler MJ
    Am J Physiol Renal Physiol; 2015 Jan; 308(1):F1-10. PubMed ID: 25339703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metadherin orchestrates PKA and PKM2 to activate β-catenin signaling in podocytes during proteinuric chronic kidney disease.
    Chen X; Xiao J; Tao D; Liang Y; Chen S; Shen L; Li S; Zheng Z; Zeng Y; Luo C; Peng F; Long H
    Transl Res; 2024 Apr; 266():68-83. PubMed ID: 37995969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpastatin prevents Angiotensin II-mediated podocyte injury through maintenance of autophagy.
    Bensaada I; Robin B; Perez J; Salemkour Y; Chipont A; Camus M; Lemoine M; Guyonnet L; Lazareth H; Letavernier E; Hénique C; Tharaux PL; Lenoir O
    Kidney Int; 2021 Jul; 100(1):90-106. PubMed ID: 33675847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PFKFB3 downregulation aggravates Angiotensin II-induced podocyte detachment.
    Huang X; Chen Z; Luo Z; Hao Y; Feng J; Zhu Z; Yang X; Zhang Z; Hu J; Liang W; Ding G
    Ren Fail; 2023 Dec; 45(1):2230318. PubMed ID: 37427767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of a local renin angiotensin system in podocytes by glucose.
    Durvasula RV; Shankland SJ
    Am J Physiol Renal Physiol; 2008 Apr; 294(4):F830-9. PubMed ID: 18216149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes.
    Campbell KN; Raij L; Mundel P
    Curr Diabetes Rev; 2011 Jan; 7(1):3-7. PubMed ID: 21067505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of the antioxidant protein peroxiredoxin 2 contributes to angiotensin II-mediated podocyte apoptosis.
    Hsu HH; Hoffmann S; Di Marco GS; Endlich N; Peter-Katalinić J; Weide T; Pavenstädt H
    Kidney Int; 2011 Nov; 80(9):959-969. PubMed ID: 21814176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of podocyte FAK protects against proteinuria and foot process effacement.
    Ma H; Togawa A; Soda K; Zhang J; Lee S; Ma M; Yu Z; Ardito T; Czyzyk J; Diggs L; Joly D; Hatakeyama S; Kawahara E; Holzman L; Guan JL; Ishibe S
    J Am Soc Nephrol; 2010 Jul; 21(7):1145-56. PubMed ID: 20522532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.